Patents Assigned to Gulch Pharma AB
  • Oral formulation comprising a crystalline form of rabeximod
    Patent number: 12673056
    Abstract: The present invention relates to a solid oral composition comprising a crystalline form of Rabeximod or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable additive.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: July 7, 2026
    Assignee: Gulch Pharma AB
    Inventor: Ulf Björklund
  • Method for preparing a crystalline form of rabeximod
    Patent number: 12594274
    Abstract: The present invention relates to a process for preparing 9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo-[2,3-b]quinoxaline, wherein said process is suitable for large scale synthesis.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: April 7, 2026
    Assignee: Gulch Pharma AB
    Inventor: Ulf Björklund